Table 3 Treatment modalities and outcomes of RMPP and non-RMPP groups.

From: Combining circ_0054633 and clinical features to predict refractory Mycoplasma pneumoniae pneumonia in children

Parameter

RMPP (n = 47)

Non-RMPP (n = 197)

P-value

Glucocorticoids, n (%)

47 (100%)

96 (48.73%)

< 0.001

IVIG, n (%)

6 (12.77%)

0 (0%)

0.001

Bronchoscopy, n (%)

39 (82.98%)

72 (36.55%)

< 0.001

Macrolide resistance, n (%)

45 (95.74%)

180 (91.37%)

0.540

Hospital stay (days)

9 [6–12]

7 [5–8]

< 0.001

Back to article page